dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Borghaei, Hossein |
dc.contributor.author | Gettinger, Scott |
dc.contributor.author | Vokes, Everett |
dc.contributor.author | Chow, Laura |
dc.contributor.author | Burgio, Marco Angelo |
dc.contributor.author | de Castro Carpeno, Javier |
dc.contributor.author | Felip Font, Enriqueta |
dc.date.accessioned | 2022-06-07T12:46:24Z |
dc.date.available | 2022-06-07T12:46:24Z |
dc.date.issued | 2021-03-01 |
dc.identifier.citation | Borghaei H, Gettinger S, Vokes EE, Chow LQM, Burgio MA, de Castro Carpeno J, et al. Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer. J Clin Oncol. 2021 Mar 1;39(7):723–33. |
dc.identifier.issn | 1527-7755 |
dc.identifier.uri | https://hdl.handle.net/11351/7634 |
dc.description | Nivolumab; Docetaxel; Càncer de pulmó |
dc.language.iso | eng |
dc.publisher | American Society of Clinical Oncology |
dc.relation.ispartofseries | Journal of Clinical Oncology;39(7) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject | Pulmons - Càncer - Tractament |
dc.subject | Immunoteràpia |
dc.subject.mesh | Carcinoma, Non-Small-Cell Lung |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Immunotherapy |
dc.subject.mesh | Treatment Outcome |
dc.title | Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1200/JCO.20.01605 |
dc.subject.decs | carcinoma de pulmón de células no pequeñas |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | inmunoterapia |
dc.subject.decs | resultado del tratamiento |
dc.relation.publishversion | https://doi.org/10.1200/JCO.20.01605 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Borghaei H] Fox Chase Cancer Center, Philadelphia, PA. [Gettinger S] Yale Comprehensive Cancer Center, New Haven, CT. [Vokes EE] Univeristy of Chicago Medicine and Biologic Sciences Division, Chicago, IL. [Chow LQM] University of Washington, Seattle Cancer Care Alliance, Seattle, WA. [Burgio MA] Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. [de Castro Carpeno J] Hospital De Madrid, Norte Sanchinarro, Madrid, Spain. [Felip E] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 33449799 |
dc.identifier.wos | 000635371200005 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |